封面
市场调查报告书
商品编码
1587502

重组蛋白市场规模、份额、趋势分析报告:按产品、应用、最终用途、宿主细胞、地区、细分市场预测,2025-2030 年

Recombinant Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies), By Application (Therapeutics), By End Use, By Host Cell (Mammalian), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

重组蛋白市场成长与趋势

预计2030年,全球重组蛋白市场规模将达到55.8亿美元,2025年至2030年复合年增长率预计为10.2%。

多发性硬化症、嗜中性白血球低下症、脑出血、贫血和侏儒症等疾病变得越来越常见,推动了对重组蛋白药物的需求。此外,由于生技药品开发和研究活性化,预计该行业将扩大,这将极大地支持世界产业的成长。由于癌症发病率和盛行率上升以及研发活动不断扩大,生物相似药、生技药品和重组蛋白的开发越来越受到关注。

根据美国癌症协会预测,2022 年将新增 190 万癌症病例,并有 609,360 例癌症相关死亡。此外,重组蛋白在 ELISA、蛋白质印迹和免疫组织化学 (IHC) 等临床诊断方法中的应用越来越多,预计将推动市场扩张。由于研发支出增加、癌症患者数量增加以及对新颖和客製化治疗的需求等因素,预计全球产业将在预测期内大幅扩张。 COVID-19 大流行导致重组蛋白片段的研究活动增加,以了解病毒动态。随着客製化的治疗,重组蛋白的产量显着增加。

此外,随着重组蛋白(尤其是与 COVID-19 相关的免疫反应蛋白)的需求和产量增加,研究资金预计将变得更加容易获得。因此,我们看到专门针对 COVID-19 提供产品的公司产生了积极影响。重组蛋白被认为是天然蛋白的改良版本,可以透过多种方式生产,以提高蛋白质产量、製造有用的商业产品和修改基因序列。全球产业的主要驱动力是製药公司研发成本的增加、慢性病的高发生率、监管要求的增加以及减少病毒感染的持续需求。

在预测期内,全球产业预计将受到重组蛋白合成技术进步的推动。例如,2022年6月,国家生物技术资讯中心产生的资料显示,CRISPR/Cas9、TALEN、锌指介导以及基因改造或顺基因技术等新育种技术将比新兴技术更有可能获得核准。促进体外基因编辑或操作。此外,新兴国家人口老化、收入水准提高、医疗基础设施改善、医疗成本上升以及低成本製造等优势预计将推动市场参与企业投资该地区并推动市场成长。

重组蛋白市场报告亮点

  • 2024年,细胞激素和生长因子细分市场占最大份额,达到24.6%。预计该细分市场将在预测期内呈指数级增长。
  • 由于代谢紊乱、癌症、遗传疾病和免疫疾病等多种疾病的流行,治疗领域在 2024 年以 34.2% 的份额主导全球市场。
  • 2024 年,製药和生技公司细分市场占据最大市场占有率,达到 38.1%。对生技药品和生物相似药的关注导致生物製造商在研发方面投入了数百万美元,以扩大产品平臺、发明新技术和改进生物製程工具。
  • 2024年重组蛋白市场中,哺乳动物细分市场占最大销售份额,达42.1%。
  • 由于该地区慢性病发病率不断上升、尖端治疗方法的使用、主要企业的存在以及医疗保健支出的增加,北美将在 2024 年成为主导地区。

目录

第一章重组蛋白市场:调查方法与范围

第二章重组蛋白市场:执行摘要

  • 市场展望
  • 段简介
  • 竞争格局概览

第三章重组蛋白市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场趋势及展望
    • 市场动态
    • 市场限制因素分析
  • 营商环境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19 影响分析

第四章 产品经营分析

  • 产品细分仪表板
  • 重组蛋白市场:产品变异分析
  • 2018-2030年全球重组蛋白市场规模及趋势分析(分产品)
  • 细胞激素和生长因子
    • 细胞激素和生长因子市场,2018-2030
    • 干扰素(IFN)
    • 白细胞介素(IL)
    • 其他的
  • 抗体
    • 抗体,2018-2030
  • 免疫查核点蛋白
    • 免疫查核点蛋白市场,2018-2030
  • 病毒抗原
    • 2018-2030年病毒抗原市场
  • 酵素
    • 酵素市场,2018-2030
    • 激酶
    • 代谢酵素
    • 其他的
  • 重组调节蛋白
    • 重组调节蛋白市场,2018-2030
  • 荷尔蒙
    • 荷尔蒙市场,2018-2030
  • 其他的
    • 其他市场,2018-2030

第五章 宿主细胞业务分析

  • 宿主细胞细分仪表板
  • 重组蛋白市场:宿主细胞变异分析
  • 2018-2030年全球重组蛋白市场规模及趋势分析(依宿主细胞)
  • 哺乳动物细胞
    • 哺乳动物细胞市场,2018-2030
  • 细菌细胞
    • 细菌细胞市场,2018-2030
  • 酵母和真菌
    • 酵母和真菌市场,2018-2030
  • 昆虫细胞
    • 昆虫细胞市场,2018-2030
  • 其他的
    • 其他市场,2018-2030

第六章 应用业务分析

  • 使用细分仪表板
  • 重组蛋白市场:应用变异分析
  • 2018-2030年全球重组蛋白市场规模及趋势分析(依应用)
  • 药物发现与开发
    • 药物发现与开发市场,2018-2030
  • 治疗
    • 生技药品
    • 疫苗
    • 细胞/基因治疗
    • 其他的
  • 研究
    • 研究市场,2018-2030
  • 其他的
    • 其他市场,2018-2030

第七章 最终用途业务分析

  • 最终用途细分仪表板
  • 重组蛋白市场:最终用途变异分析
  • 2018-2030 年全球重组蛋白市场规模与趋势分析(依最终用途)
  • 製药和生物技术公司
    • 製药和生物技术市场,2018-2030
  • 学术研究所
    • 学术研究机构市场,2018-2030
  • 其他的
    • 其他市场,2018-2030

第八章区域业务分析

  • 区域仪表板
  • 2024 年和 2030 年按地区分類的全球市场占有率
  • 北美洲
    • 北美重组蛋白市场,2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲重组蛋白市场,2018-2030
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太重组蛋白市场,2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 拉丁美洲重组蛋白市场,2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东和非洲重组蛋白市场,2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 公司分类
  • 策略规划
  • 2024 年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Sino Biological, Inc.
    • GenScript
    • Bio-Techne
    • Proteintech Group, Inc.
    • Enzo Life Sciences, Inc.
    • Abnova Corp
    • RayBIoTech Life Inc.
    • STEMCELL Technologies Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
Product Code: GVR-4-68039-974-2

Recombinant Proteins Market Growth & Trends:

The global recombinant proteins market size is expected to reach USD 5.58 billion in 2030 and is projected to grow at a CAGR of 10.2% from 2025 to 2030. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.

According to the American Cancer Society, in 2022, there will be 1.9 million new cancer cases and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion. Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period. Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19. Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The main drivers of the global industry are the rise in pharmaceutical firms' R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections.

Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins. For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved. In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling market growth.

Recombinant Proteins Market Report Highlights:

  • The cytokines & growth factors segment held the largest share of 24.6% of the market in 2024. This segment is anticipated to grow exponentially throughout the forecast period.
  • The therapeutics segment dominated the global market with a share of 34.2% in 2024 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases.
  • The pharma & biotechnology companies segment captured the largest market share of 38.1% in 2024. The inclination towards biologics and biosimilars has resulted in a cascade of multi-million investments by bio-manufacturers in R&D to grow the pipeline of products, devise new technologies, and advance bioprocessing tools.
  • The mammalian segment held the largest revenue share of 42.1% of the recombinant proteins market in 2024.
  • North America was the dominant region in 2024 due to an increase in the incidence of chronic diseases, use of cutting-edge treatments, the presence of key players, and a rise in healthcare spending in the region.

Table of Contents

Chapter 1. Recombinant Proteins Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Host Cell Segment
    • 1.2.3. Application Segment
    • 1.2.4. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives

Chapter 2. Recombinant Proteins Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Recombinant Proteins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
    • 3.2.1. Market Dynamics
      • 3.2.1.1. Increasing Investments In Research & Development Activities
      • 3.2.1.2. Growing research activities for drug discovery and precision medicine
      • 3.2.1.3. Rising adoption of biologics & biosimilars
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory and safety concerns regarding protein production
      • 3.2.2.2. Dearth of skilled personnel and expertise
  • 3.3. Business Environment Analysis
    • 3.3.1. PESTEL Analysis
    • 3.3.2. Porter's Five Forces Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Recombinant Proteins Market: Product Movement Analysis
  • 4.3. Global Recombinant Proteins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cytokines & Growth Factors
    • 4.4.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.4.2. Interferons (IFNs)
      • 4.4.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
    • 4.4.3. Interleukins (ILs)
      • 4.4.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Antibodies
    • 4.5.1. Antibodies, 2018 - 2030 (USD Million)
  • 4.6. Immune Checkpoint Proteins
    • 4.6.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
  • 4.7. Virus Antigens
    • 4.7.1. Virus Antigens Market, 2018 - 2030 (USD Million)
  • 4.8. Enzymes
    • 4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.2. Kinases
      • 4.8.2.1. Kinases Market, 2018 - 2030 (USD Million)
    • 4.8.3. Metabolic Enzymes
      • 4.8.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.4. Others
      • 4.8.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.9. Recombinant Regulatory Proteins
    • 4.9.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
  • 4.10. Hormones
    • 4.10.1. Hormones Market, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

  • 5.1. Host Cell Segment Dashboard
  • 5.2. Recombinant Proteins Market: Host Cell Movement Analysis
  • 5.3. Global Recombinant Proteins Market Size & Trend Analysis, by Host Cell, 2018 to 2030 (USD Million)
  • 5.4. Mammalian Cells
    • 5.4.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
  • 5.5. Bacterial Cells
    • 5.5.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 5.6. Yeast & Fungi
    • 5.6.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 5.7. Insect Cells
    • 5.7.1. Insect Cells Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Recombinant Proteins Market: Application Movement Analysis
  • 6.3. Global Recombinant Proteins Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Drug Discovery & Development
    • 6.4.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
  • 6.5. Therapeutics
    • 6.5.1. Biologics
      • 6.5.1.1. Biologics Market, 2018 - 2030 (USD Million)
    • 6.5.2. Vaccines
      • 6.5.2.1. Vaccines Market, 2018 - 2030 (USD Million)
    • 6.5.3. Cell & Gene Therapies
      • 6.5.3.1. Cell & Gene Therapies Market, 2018 - 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others Market, 2018 - 2030 (USD Million)
  • 6.6. Research
    • 6.6.1. Research Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Recombinant Proteins Market: End-use Movement Analysis
  • 7.3. Global Recombinant Proteins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Global Market Share By Region, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. U.S. Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Canada Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. UK Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Germany Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.4. Spain
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Spain Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.5. France
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. France Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.6. Italy
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Italy Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Denmark Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Sweden Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Norway Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia-Pacific Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Japan Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. China Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. India Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. South Korea Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Thailand Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Australia Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Brazil Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Mexico Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Scenario
      • 8.6.4.4. Argentina Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. South Africa Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Saudi Arabia Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. UAE Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Kuwait Recombinant Proteins Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Sino Biological, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Benchmarking
      • 9.4.2.3. Strategic Initiatives
    • 9.4.3. GenScript
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Bio-Techne
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Proteintech Group, Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Benchmarking
      • 9.4.5.3. Strategic Initiatives
    • 9.4.6. Enzo Life Sciences, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Benchmarking
      • 9.4.6.3. Strategic Initiatives
    • 9.4.7. Abnova Corp
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Benchmarking
      • 9.4.7.3. Strategic Initiatives
    • 9.4.8. RayBiotech Life Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Benchmarking
      • 9.4.8.3. Strategic Initiatives
    • 9.4.9. STEMCELL Technologies Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Benchmarking
      • 9.4.9.3. Strategic Initiatives
    • 9.4.10. Bio-Rad Laboratories, Inc.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Benchmarking
      • 9.4.10.3. Strategic Initiatives
    • 9.4.11. Merck KGaA
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Benchmarking
      • 9.4.11.3. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 7 Global Recombinant Protein Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 12 North America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 13 U.S. Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 16 U.S. Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 17 Canada Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 20 Canada Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 21 Mexico Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Mexico Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 25 Europe Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Europe Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Europe Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 29 Europe Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 30 Germany Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Germany Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 33 Germany Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 34 UK Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 UK Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 UK Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 37 UK Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 38 France Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 France Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 France Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 41 France Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 42 Italy Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Italy Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Italy Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 45 Italy Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 46 Spain Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Spain Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 49 Spain Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 50 Denmark Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Denmark Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 53 Denmark Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 54 Sweden Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Sweden Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 57 Sweden Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 58 Norway Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Norway Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Norway Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 61 Norway Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million
  • Table 62 Asia Pacific Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 67 China Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 China Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 70 China Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 71 Japan Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Japan Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 74 Japan Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 75 India Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 India Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 India Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 78 India Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 79 South Korea Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Korea Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 82 South Korea Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 83 Australia Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Australia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 86 Australia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 87 Thailand Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 90 Thailand Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 91 Latin America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Latin America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Latin America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 95 Latin America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 96 Brazil Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Brazil Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Brazil Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 99 Brazil Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 100 Argentina Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Argentina Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 103 Argentina Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 109 South Africa Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 South Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 112 South Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 117 UAE Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 UAE Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 120 UAE Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 125 Participant's Overview
  • Table 126 Financial Performance
  • Table 127 Key Companies Undergoing Expansions
  • Table 128 Key Companies Undergoing Acquisitions
  • Table 129 Key Companies Undergoing Collaborations
  • Table 130 Key Companies Launching New Products/Services
  • Table 131 Key Companies Undergoing Partnerships
  • Table 132 Key Companies Undertaking Other Strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Recombinant Protein, Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis
  • Fig. 11 Market Restraint Relevance Analysis (Porter's Five Forces Analysis
  • Fig. 12 Global Recombinant Protein Market: Product Movement Analysis
  • Fig. 13 Global Recombinant Protein Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 14 Global Recombinant Protein Market: Application Movement Analysis
  • Fig. 15 Global Recombinant Protein Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
  • Fig. 16 Global Recombinant Protein Market, for Therapeutics, 2018 - 2030 (USD Million)
  • Fig. 17 Global Recombinant Protein Market, for Research , 2018 - 2030 (USD Million)
  • Fig. 18 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Recombinant Protein Market: End Use Movement Analysis
  • Fig. 20 Global Recombinant Protein Market, for Pharma & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 21 Global Recombinant Protein Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 22 Global Recombinant Protein Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 23 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 24 Global Recombinant Protein Market: Host Cell Movement Analysis
  • Fig. 25 Global Recombinant Protein Market, for Mammalian systems, 2018 - 2030 (USD Million)
  • Fig. 26 Global Recombinant Protein Market, for Insect Cells, 2018 - 2030 (USD Million)
  • Fig. 27 Global Recombinant Protein Market, for Yeast & Fungi, 2018 - 2030 (USD Million)
  • Fig. 28 Global Recombinant Protein Market, for Bacterial Cells, 2018 - 2030 (USD Million)
  • Fig. 29 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 Regional Outlook, 2024 & 2030
  • Fig. 32 Global Recombinant Protein Market: Region Movement Analysis
  • Fig. 33 North America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 34 US Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 40 France Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 48 China Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 49 India Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 61 Market participant categorization
  • Fig. 62 Recombinant Proteins Market Position Analysis, 2024
  • Fig. 63 Strategy framework